Insider Transactions in Q1 2025 at Pacific Premier Bancorp Inc (PPBI)
Insider Transaction List (Q1 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 31
2025
|
Margaret S. Ohlhaver Sr.EVP, Chf Human Res. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
251
-0.72%
|
$5,271
$21.32 P/Share
|
Mar 31
2025
|
Michael S Karr SEVP & Chief Risk Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,616
-4.8%
|
$33,936
$21.32 P/Share
|
Mar 31
2025
|
Donn Bordon Jakosky Sr, EVP & Chief Credit Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
430
-0.7%
|
$9,030
$21.32 P/Share
|
Mar 31
2025
|
Steven R Arnold General Counsel & Corp. Sec. |
SELL
Payment of exercise price or tax liability
|
Direct |
508
-0.99%
|
$10,668
$21.32 P/Share
|
Mar 31
2025
|
Tom Rice SEVP/ Chief Innovation Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,102
-6.07%
|
$44,142
$21.32 P/Share
|
Mar 31
2025
|
Sherri V. Scott SrEVP, Chief Corp Resp Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
72
-0.18%
|
$1,512
$21.32 P/Share
|
Mar 18
2025
|
Stephanie Hsieh Director |
BUY
Bona fide gift
|
Indirect |
3,317
+28.28%
|
-
|
Mar 18
2025
|
Stephanie Hsieh Director |
SELL
Bona fide gift
|
Direct |
3,317
-46.6%
|
-
|
Mar 18
2025
|
Jeff C Jones Director |
BUY
Bona fide gift
|
Indirect |
3,317
+2.4%
|
-
|
Mar 18
2025
|
Jeff C Jones Director |
SELL
Bona fide gift
|
Direct |
3,317
-27.15%
|
-
|
Mar 18
2025
|
Michael S Karr SEVP & Chief Risk Officer |
BUY
Bona fide gift
|
Indirect |
7,343
+7.8%
|
-
|
Mar 18
2025
|
Michael S Karr SEVP & Chief Risk Officer |
SELL
Bona fide gift
|
Direct |
7,343
-17.91%
|
-
|
Mar 18
2025
|
Ronald J. Nicolas Jr. SEVP & CFO |
BUY
Bona fide gift
|
Indirect |
34,107
+20.07%
|
-
|
Mar 18
2025
|
Ronald J. Nicolas Jr. SEVP & CFO |
SELL
Bona fide gift
|
Direct |
34,107
-34.18%
|
-
|
Mar 18
2025
|
Tom Rice SEVP/ Chief Innovation Officer |
BUY
Bona fide gift
|
Indirect |
7,550
+8.57%
|
-
|
Mar 18
2025
|
Tom Rice SEVP/ Chief Innovation Officer |
SELL
Bona fide gift
|
Direct |
7,550
-17.89%
|
-
|
Mar 18
2025
|
Richard C Thomas Director |
BUY
Bona fide gift
|
Indirect |
3,317
+14.82%
|
-
|
Mar 18
2025
|
Richard C Thomas Director |
SELL
Bona fide gift
|
Direct |
3,317
-46.6%
|
-
|
Mar 15
2025
|
Stephanie Hsieh Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,801
+34.81%
|
-
|
Mar 15
2025
|
Jeff C Jones Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,801
+23.73%
|
-
|
Mar 15
2025
|
Steven R Arnold General Counsel & Corp. Sec. |
SELL
Payment of exercise price or tax liability
|
Direct |
2,951
-5.41%
|
$64,922
$22.36 P/Share
|
Mar 15
2025
|
Steven R Arnold General Counsel & Corp. Sec. |
BUY
Grant, award, or other acquisition
|
Direct |
12,299
+18.41%
|
-
|
Mar 15
2025
|
Michael S Karr SEVP & Chief Risk Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,574
-17.3%
|
$188,628
$22.36 P/Share
|
Mar 15
2025
|
Michael S Karr SEVP & Chief Risk Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,914
+2.83%
|
-
|
Mar 15
2025
|
Michael S Karr SEVP & Chief Risk Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,653
+25.12%
|
-
|
Mar 15
2025
|
Ronald J. Nicolas Jr. SEVP & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,244
+3.01%
|
-
|
Mar 15
2025
|
Ronald J. Nicolas Jr. SEVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
33,542
+26.39%
|
-
|
Mar 15
2025
|
Avad Adeeb Fargo Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,801
+14.85%
|
-
|
Mar 15
2025
|
Jaynie M Studenmund Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,801
+18.18%
|
-
|
Mar 15
2025
|
Zareh Hovik Sarrafian Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,801
+7.41%
|
-
|
Mar 15
2025
|
Barbara Polsky Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,801
+17.19%
|
-
|
Mar 15
2025
|
Donn Bordon Jakosky Sr, EVP & Chief Credit Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,078
-4.79%
|
$67,716
$22.36 P/Share
|
Mar 15
2025
|
Donn Bordon Jakosky Sr, EVP & Chief Credit Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,299
+16.07%
|
-
|
Mar 15
2025
|
Lori R Wright Sr. EVP, Deputy CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,588
-8.24%
|
$78,936
$22.36 P/Share
|
Mar 15
2025
|
Lori R Wright Sr. EVP, Deputy CFO |
BUY
Grant, award, or other acquisition
|
Direct |
12,299
+22.02%
|
-
|
Mar 15
2025
|
M Christian Mitchell Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,919
+11.18%
|
-
|
Mar 15
2025
|
Rose Mckinney James Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,801
+23.69%
|
-
|
Mar 15
2025
|
George M. Pereira Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,801
+23.81%
|
-
|
Mar 15
2025
|
Tom Rice SEVP/ Chief Innovation Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,367
-16.54%
|
$184,074
$22.36 P/Share
|
Mar 15
2025
|
Tom Rice SEVP/ Chief Innovation Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,914
+2.78%
|
-
|
Mar 15
2025
|
Tom Rice SEVP/ Chief Innovation Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,653
+24.72%
|
-
|
Mar 15
2025
|
Steven R Gardner Chairman, President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
35,784
-14.79%
|
$787,248
$22.36 P/Share
|
Mar 15
2025
|
Steven R Gardner Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
17,900
+3.53%
|
-
|
Mar 15
2025
|
Steven R Gardner Chairman, President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
70,438
+23.92%
|
-
|
Mar 15
2025
|
Edward Earl Wilcox President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
20,817
-11.85%
|
$457,974
$22.36 P/Share
|
Mar 15
2025
|
Edward Earl Wilcox President & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,077
+1.96%
|
-
|
Mar 15
2025
|
Edward Earl Wilcox President & COO |
BUY
Grant, award, or other acquisition
|
Direct |
38,014
+18.41%
|
-
|
Mar 15
2025
|
Richard C Thomas Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,801
+34.81%
|
-
|
Mar 15
2025
|
Margaret S. Ohlhaver Sr.EVP, Chf Human Res. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,951
-7.81%
|
$64,922
$22.36 P/Share
|
Mar 15
2025
|
Margaret S. Ohlhaver Sr.EVP, Chf Human Res. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,299
+24.56%
|
-
|